150 related articles for article (PubMed ID: 26779809)
1. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer.
Roßner F; Gieseler C; Morkel M; Royer HD; Rivera M; Bläker H; Dietel M; Schäfer R; Sers C
Oncogenesis; 2016 Jan; 5(1):e187. PubMed ID: 26779809
[TBL] [Abstract][Full Text] [Related]
2. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
3. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy.
Kasper S; Reis H; Ziegler S; Nothdurft S; Mueller A; Goetz M; Wiesweg M; Phasue J; Ting S; Wieczorek S; Even A; Worm K; Pogorzelski M; Breitenbuecher S; Meiler J; Paul A; Trarbach T; Schmid KW; Breitenbuecher F; Schuler M
Oncotarget; 2017 Jul; 8(28):45898-45917. PubMed ID: 28507280
[TBL] [Abstract][Full Text] [Related]
5. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Yue D; Wang Y; Sun Y; Niu Y; Chang C
Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
[TBL] [Abstract][Full Text] [Related]
6. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
7. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis.
Guo C; Sun Y; Zhai W; Yao X; Gong D; You B; Huang CP; Zheng J; Chang C
Cell Biosci; 2022 Nov; 12(1):185. PubMed ID: 36397101
[TBL] [Abstract][Full Text] [Related]
9. Loss of CDH1 up-regulates epidermal growth factor receptor via phosphorylation of YBX1 in non-small cell lung cancer cells.
Liu X; Su L; Liu X
FEBS Lett; 2013 Dec; 587(24):3995-4000. PubMed ID: 24211838
[TBL] [Abstract][Full Text] [Related]
10. Elevated nuclear YBX1 expression and the clinicopathological characteristics of patients with solid tumors: a meta-analysis.
Zhang C; Yin T; Tao R; Xiao B; Chen J; Li Z; Miao X; Peng Q; Sun L; Zhang W; Ren J; Zhang Z; Zhang Y; Li X; Zhang W
Cancer Manag Res; 2019; 11():4391-4402. PubMed ID: 31191002
[No Abstract] [Full Text] [Related]
11. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
12. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling.
Tintelnot J; Metz S; Trentmann M; Oberle A; von Wenserski L; Schultheiß C; Braig F; Kriegs M; Fehse B; Riecken K; Bokemeyer C; Stein A; Binder M
Front Oncol; 2019; 9():1559. PubMed ID: 32039027
[TBL] [Abstract][Full Text] [Related]
14. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
15. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.
Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH; Ju YC; Wang MX; Li ZX
Curr Cancer Drug Targets; 2018; 18(3):278-286. PubMed ID: 28359236
[TBL] [Abstract][Full Text] [Related]
16. High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma.
Zhao S; Guo W; Li J; Yu W; Guo T; Deng W; Gu C
Onco Targets Ther; 2016; 9():2683-92. PubMed ID: 27217779
[TBL] [Abstract][Full Text] [Related]
17. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
[TBL] [Abstract][Full Text] [Related]
18. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
19. Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer.
Prabhu L; Mundade R; Wang B; Wei H; Hartley AV; Martin M; McElyea K; Temm CJ; Sandusky G; Liu Y; Lu T
Oncotarget; 2015 Oct; 6(30):29396-412. PubMed ID: 26318844
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
